Moderna(MRNA) - 2023 Q3 - Earnings Call Presentation
Moderna(MRNA)2023-11-02 12:00© 2023 Moderna, Inc. All rights reserved. © 2023 Moderna, Inc. All rights reserved. Business Review Stéphane Bancel, CEO © 2023 Moderna, Inc. All rights reserved. COVID product (Spikevax) sales Increasing Spikevax share in the current season1 Resizing manufacturing footprint to accelerate gross margin expansion toward longer-term target of 75-80% 4 © 2023 Moderna, Inc. All rights reserved. Commercial Market Arpa Garay, CCO Looking Forward Stéphane Bancel, CEO 3Q23 Spikevax sales of $1.8B; updating sales out ...